Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts"

Journal of Analytical Toxicology

Volumn 37, Issue 3, 2013, Pages 182-185

  Wyman, John F ^a   Lavins, Eric S ^a   Engelhart, David ^b   Armstrong, Erica J ^a   Snell, Kimberly D ^a   Boggs, Paul D ^a   Taylor, Shaena M ^a   Norris, Rindi N ^c   Miller, Frank P ^a  

^a Cuyahoga County Medical Examiner s Office   (United States)

^b Omega Labs Inc   (United States)

^c UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYPYROVALERONE; BENZATROPINE; CATHINONE; FLUOXETINE; IBUPROFEN; LAMOTRIGINE; PSEUDOEPHEDRINE; PSYCHOTROPIC AGENT; RISPERIDONE; SIMVASTATIN; TRAZODONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; BRAIN; CASE REPORT; CEREBROSPINAL FLUID; HAIR; HEART; HEART ARRHYTHMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTOXICATION; KIDNEY; LIQUID; LIVER; LUNG; MALE; MASS FRAGMENTOGRAPHY; MUSCLE; SOLID PHASE EXTRACTION; SPLEEN;

ADULT; ALKALOIDS; ARRHYTHMIAS, CARDIAC; AUTOPSY; BATHS; BENZODIOXOLES; BRAIN; CAUSE OF DEATH; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; FATAL OUTCOME; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HAIR; HUMANS; LUNG; MALE; MUSCLE, SKELETAL; PSYCHOTROPIC DRUGS; PYRROLIDINES; SOLID PHASE EXTRACTION; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 84875264411     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt001     Document Type: Article

References (17)

1. [2011] Situation Report: Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat. U.S. Department of Justice, National Drug Intelligence Center, Product Number 2011-S0787-004.
2. Frazee, C.C., Johnson, L., Scott, D., Garg, U. (2011) Bath salts: Analysis of three versions of new street drugs. In Barnhill, M. (ed.), Case notes, ToxTalk, Section Ed. 35 (1): 16-20.
3. [2011] Emergency department visits after use of a drug sold as "bath salts"-Michigan, November 13, 2010-March 31, 2011. Centers for Disease Control and Prevention (CDC). MMWR Morbidity and Mortality Weekly Report, 60, 624-627.
4. Spiller, H.A., Ryan, M.L., Weston, R.G., Jansen, J. (2011) Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clinical Toxicology (Philadelphia), 49, 499-505.
5. [2011(] Schedule of Controlled Substances: Temporary Placement of Three Synthetic Cathinones into Schedule I. 21 CFR Part 1308. Docket No. DEA-357. Federal Register Vol. 76. No. 204/Rules and Regulations.
6. Coppola, M., Mondola, R. (2012) 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicology Letters, 208, 12-15.
7. Murray, B.L., Murphy, C.M., Beuhler, M.C. (2012) Death following recreational use of designer drug "Bath Salts" containing 3,4-methylenedioxypyrovalerone (MDPV). Journal of Medical Toxicology, 8, 69-75.
8. Therapeutic and abused drugs in serum, plasma or whole blood for GC or GC/MS confirmations using: 200 mg Clean Screen extraction columns (technical procedure 2011), Procedure Code: DRB200DAUZ050191. Worldwide Monitoring Corporation publication: Applications Manual, p11.
9. Kalapos, M.P. (2011) 3-4-Methylene-dioxy-pyrovalerone (MDPV) epidemic? Orvosi Hetilap/Hungarian Medical Journal, 152, 2010-2019.
10. Bork, J.A., Roger, T., Wedlund, P.J., de Leon, J. (1999) A pilot study on risperidone metabolism: The role of cytochromes P450 2D6 and 3A. Journal of Clinical Psychiatry, 60, 469-476.
11. Yasui-Furukori, N., Hidestrand, M., Spina, E., Facciola, G., Scordo, M.G., Tybring, G. (2001) Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. Drug Metabolism and Disposition, 29, 1263-1268.
12. LamoTRIgine Drug Information Provided by Lexi-Comp, Merck Manual for Health Care Professionals. http://www.merckmanuals. com/professional/lexicomp/lamotrigine.html (accessed 25 September, 2012).
13. Baselt, R.C. (ed.) Disposition of toxic drugs and chemicals in man, 9th edition (2011). Biomedical Publications, Seal Beach, CA, p. 1457.
14. [2011] FLUoxetine Drug Information Provided by Lexi-Comp, Merck Manual for Health Care Professionals. http://www.merckmanuals.com/ professional/lexicomp/fluoxetine.html (accessed 25 September, 2012).
15. Lusthof, K.J., Oosting, R., Maes, A., Verschraagen, M., Dijkhuizen, A., Sprong, A.G.A. (2011) A case of extreme agitation and death after the use of mephedrone in the Netherlands. Forensic Science International, 206, e93-e95.
16. Maskell, P.D., DePaoli, G., Sneviratne, C., Pounder, D.J. (2011) Mephedrone (4-methylmethcathinone)-related deaths. Journal of Analytical Toxicology, 35, 188-191.
17. Cawrse, B.M., Levine, B., Jufer, R.A., Fowler, D.R., Vorce, S.P., Dickson, A.J. et al. (2012) Distribution of methylone in four postmortem cases. Journal of Analytical Toxicology, 36, 434-439.